ACE2 and COVID-19: We have recently found evidence that SARS-CoV-2-infected cells have a downregulation of ACE2 mRNA expression and a reduced cell surface expression of ACE2 and that COVID-19 patients have decreased soluble ACE2 and increased levels of Ang II in their plasma (196).